These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
518 related articles for article (PubMed ID: 27766598)
21. Depot formulations to sustain periocular drug delivery to the posterior eye segment. Agban Y; Thakur SS; Mugisho OO; Rupenthal ID Drug Discov Today; 2019 Aug; 24(8):1458-1469. PubMed ID: 30930148 [TBL] [Abstract][Full Text] [Related]
22. Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye. Wang Y; Xu X; Gu Y; Cheng Y; Cao F Expert Opin Drug Deliv; 2018 Jul; 15(7):687-701. PubMed ID: 29985660 [TBL] [Abstract][Full Text] [Related]
24. Posterior drug delivery via periocular route: challenges and opportunities. Waite D; Wang Y; Jones D; Stitt A; Raj Singh TR Ther Deliv; 2017 Jul; 8(8):685-699. PubMed ID: 28730942 [TBL] [Abstract][Full Text] [Related]
25. Topical delivery of ocular therapeutics: carrier systems and physical methods. Souza JG; Dias K; Pereira TA; Bernardi DS; Lopez RF J Pharm Pharmacol; 2014 Apr; 66(4):507-30. PubMed ID: 24635555 [TBL] [Abstract][Full Text] [Related]
26. Microspheres and Nanotechnology for Drug Delivery. Jóhannesson G; Stefánsson E; Loftsson T Dev Ophthalmol; 2016; 55():93-103. PubMed ID: 26501994 [TBL] [Abstract][Full Text] [Related]
28. Nanomedicines for back of the eye drug delivery, gene delivery, and imaging. Kompella UB; Amrite AC; Pacha Ravi R; Durazo SA Prog Retin Eye Res; 2013 Sep; 36():172-98. PubMed ID: 23603534 [TBL] [Abstract][Full Text] [Related]
29. Colloidal drug delivery system: amplify the ocular delivery. Ali J; Fazil M; Qumbar M; Khan N; Ali A Drug Deliv; 2016; 23(3):710-26. PubMed ID: 24892625 [TBL] [Abstract][Full Text] [Related]
30. Nanocarriers in ocular drug delivery: an update review. Wadhwa S; Paliwal R; Paliwal SR; Vyas SP Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343 [TBL] [Abstract][Full Text] [Related]
32. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives. Gaballa SA; Kompella UB; Elgarhy O; Alqahtani AM; Pierscionek B; Alany RG; Abdelkader H Drug Deliv Transl Res; 2021 Jun; 11(3):866-893. PubMed ID: 32901367 [TBL] [Abstract][Full Text] [Related]
33. Recent patents on ocular drug delivery systems. Conway BR Recent Pat Drug Deliv Formul; 2008; 2(1):1-8. PubMed ID: 19075892 [TBL] [Abstract][Full Text] [Related]
34. Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective. Qamar Z; Qizilbash FF; Iqubal MK; Ali A; Narang JK; Ali J; Baboota S Recent Pat Drug Deliv Formul; 2019; 13(4):246-254. PubMed ID: 31884933 [TBL] [Abstract][Full Text] [Related]
35. Nanotherapies for the treatment of ocular diseases. Reimondez-Troitiño S; Csaba N; Alonso MJ; de la Fuente M Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):279-93. PubMed ID: 25725262 [TBL] [Abstract][Full Text] [Related]
36. The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies. Herrero-Vanrell R; Bravo-Osuna I; Andrés-Guerrero V; Vicario-de-la-Torre M; Molina-Martínez IT Prog Retin Eye Res; 2014 Sep; 42():27-43. PubMed ID: 24819336 [TBL] [Abstract][Full Text] [Related]
37. Nano-ophthalmology: Applications and considerations. Kamaleddin MA Nanomedicine; 2017 May; 13(4):1459-1472. PubMed ID: 28232288 [TBL] [Abstract][Full Text] [Related]
38. Drug delivery to the posterior segment of the eye. Fischer N; Narayanan R; Loewenstein A; Kuppermann BD Eur J Ophthalmol; 2011; 21 Suppl 6():S20-6. PubMed ID: 23264325 [TBL] [Abstract][Full Text] [Related]
39. Novel approaches to ocular drug delivery. Davis JL; Gilger BC; Robinson MR Curr Opin Mol Ther; 2004 Apr; 6(2):195-205. PubMed ID: 15195932 [TBL] [Abstract][Full Text] [Related]